CHEOY:OTCMKTS
Cochlear Ord ADR
44,72 US$
arrow_downward
-0,07%(-0,030) 1D
15 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHEOY...
Open
44,61 US$
High
44,82 US$
Low
44,60 US$
Mkt. cap
8,48 მლრდ.
Avg. vol.
18,50 ათ.
Volume
26,66 ათ.
52-wk high
98,49 US$
52-wk low
31,82 US$
Beta
0,68
Shares outstanding
130,80 მლნ.
No. of employees
5 ათ.
Open
44,61 US$
High
44,82 US$
Low
44,60 US$
Mkt. cap
8,48 მლრდ.
Avg. vol.
18,50 ათ.
Volume
26,66 ათ.
52-wk high
98,49 US$
52-wk low
31,82 US$
Beta
0,68
Shares outstanding
130,80 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
6 საათის წინ
UBS keeps AUD 135.00 target for Cochlear stock
Simply Wall Street
·
7 საათის წინ
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
1 დღის წინ
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ord ADR
CEODig Howitt
Employees5,4 ათ.
Founded1981
Headquartersსიდნეი, ახალი სამხრეთი უელსი, ავსტრალია
SectorMedical device
Websitecochlear.com